Figure 5. The nomogram model developed for predicting GBM patients’ prognosis. (A, B) Univariate and multivariate Cox regression analyses of the integration of risk scores and clinical parameters. (C) Development of a prognostic nomogram model for estimating GBM patients’ prognosis. (D) Calibration curve of the nomogram model at 3-, 5-, and 7-year. (E) Gene set enrichment analysis (GSEA) results, indicating the cytokine-cytokine receptor interaction, and JAK-STAT signaling pathway.